N-[(R)-4-phosphopantothenoyl]-L-cysteine

Metabolite details

Identifier

XQYALQVLCNHCFT-CBAPKCEASA-N

InChI Key

XQYALQVLCNHCFT-CBAPKCEASA-N

IUPAC name

N-{N-[(2R)-2-hydroxy-3,3-dimethyl-4-phosphonooxybutanoyl]-β-alanyl}-L-cysteine

Preferred name

N-[(R)-4-phosphopantothenoyl]-L-cysteine

INN name

—

Synonym

N-[(R)-4'-Phosphopantothenoyl]-L-cysteine

ChEBI

CHEBI:15769

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Changes and correlations of intestinal flora and liver metabolite profiles in mice with gallstones
• Jasmonate-mediated stomatal closure under elevated CO2 revealed by time-resolved metabolomics
• Diallyl disulfide (DADS) ameliorates intestinal Candida albicans infection by modulating the gut microbiota and metabolites and providing intestinal protection in mice
• Long-term low-dose ionizing radiation induced chromosome-aberration-specific metabolic phenotype changes in radiation workers
• Multi-omic Profiling of Multi-Biosamples Reveals the Role of Amino Acid and Nucleotide Metabolism in Endometrial Cancer

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_Lithogenic_Diet
• 400ppm_0min_vs_800ppm_60min
• G1_PBS_vs_G2_DSS
• LLIR_vs_Control
• Control_vs_Endometrial_Cancer